A concise and sequential synthesis of the nitroimidazooxazole based drug, Delamanid and related compounds
-
- Sumit Sharma
- Medicinal Chemistry Division
-
- Radhika Anand
- Medicinal Chemistry Division
-
- Pankaj Singh Cham
- Medicinal Chemistry Division
-
- Sushil Raina
- Medicinal Chemistry Division
-
- Ram. A. Vishwakarma
- Medicinal Chemistry Division
-
- Parvinder Pal Singh
- Medicinal Chemistry Division
抄録
<p>A concise, protection-group free and sequential route has been developed for the synthesis of the nitroimidazole based FDA-approved multi-drug resistant anti-tuberculosis drug, Delamanid and anti-leishmanial lead candidate VL-2098.</p>
収録刊行物
-
- RSC Advances
-
RSC Advances 10 (29), 17085-17093, 2020
Royal Society of Chemistry (RSC)